Management of urticarial vasculitis: A worldwide physician perspective☆

[1]  N. Dupin,et al.  Dramatic but suspensive effect of interleukin-1 inhibitors for persistent urticarial vasculitis: a French multicentre retrospective study , 2019, Annals of the rheumatic diseases.

[2]  E. Kocaturk,et al.  Omalizumab as a Succesfull Therapy in Normocomplementemic Urticarial Vasculitis: A Series of Four Patients and Review of the Literature , 2019, Annals of dermatology.

[3]  I. Chérrez-Ojeda,et al.  Autoimmune thyroid disease and urticarial vasculitis: is there a significant association? , 2019, Allergy, Asthma & Clinical Immunology.

[4]  M. Maurer,et al.  Treatment of urticarial vasculitis: A systematic review , 2019, The Journal of allergy and clinical immunology.

[5]  K. Chanprapaph,et al.  Successful treatment of normocomplementemic urticarial vasculitis with omalizumab: A report of three cases and literature review. , 2019, Asian Pacific journal of allergy and immunology.

[6]  A. Verdelli,et al.  An update on the nomenclature for cutaneous vasculitis , 2018, Current opinion in rheumatology.

[7]  A. Younis.  Urticarial vasculitis as an initial manifestation of colonic carcinoma: a case report and review of the literature. , 2018, Reumatismo.

[8]  D. Murrell,et al.  Normocomplementaemic urticarial vasculitis: effective treatment with omalizumab , 2018, Clinical and Translational Allergy.

[9]  T. Mandl,et al.  Epidemiology of hypocomplementaemic urticarial vasculitis (anti-C1q vasculitis) , 2018, Rheumatology.

[10]  T. Zuberbier,et al.  The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria , 2018, Allergy.

[11]  R. Bhat,et al.  A clinical, dermoscopic, and histopathological study of Dermatosis Papulosa Nigra (DPN) – An Indian perspective , 2017, International journal of dermatology.

[12]  B. Aksoy,et al.  Urticarial Vasculitis , 2017 .

[13]  J. Bousquet,et al.  Definition, aims, and implementation of GA2LEN Urticaria Centers of Reference and Excellence , 2016, Allergy.

[14]  L. Mouthon,et al.  The Clinical Spectrum and Therapeutic Management of Hypocomplementemic Urticarial Vasculitis: Data From a French Nationwide Study of Fifty‐Seven Patients , 2015, Arthritis & rheumatology.

[15]  C. Lohse,et al.  Incidence of leukocytoclastic vasculitis, 1996 to 2010: a population-based study in Olmsted County, Minnesota. , 2014, Mayo Clinic proceedings.

[16]  T. Zuberbier,et al.  The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. , 2014, Allergy.

[17]  K. Suh,et al.  Evolution of urticarial vasculitis: a clinical, dermoscopic and histopathological study , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[18]  T. Zuberbier,et al.  Urticarial vasculitis and Schnitzler syndrome. , 2014, Immunology and allergy clinics of North America.

[19]  M. González-Gay,et al.  Urticarial Vasculitis in Northern Spain , 2014, Medicine.

[20]  T. Zuberbier,et al.  Efficacy and safety of canakinumab in urticarial vasculitis: an open-label study. , 2013, The Journal of allergy and clinical immunology.

[21]  M. Maurer,et al.  Practical algorithm for diagnosing patients with recurrent wheals or angioedema , 2013, Allergy.

[22]  J. Carlson.  The histological assessment of cutaneous vasculitis , 2010, Histopathology.

[23]  S. Jiamton,et al.  Urticarial vasculitis: etiologies and clinical course. , 2009, Asian Pacific journal of allergy and immunology.

[24]  H. Baba,et al.  Hypocomplementemic urticarial vasculitis syndrome: an interdisciplinary challenge. , 2009, Deutsches Arzteblatt international.

[25]  M. Venturini,et al.  A reassessment of diagnostic criteria and treatment of idiopathic urticarial vasculitis: a retrospective study of 47 patients , 2009, Clinical and experimental dermatology.

[26]  S. Pulimood,et al.  Clinicopathologic profile of normocomplementemic and hypocomplementemic urticarial vasculitis: a study from South India , 2008, Journal of the European Academy of Dermatology and Venereology.

[27]  J. Brewer,et al.  Urticarial vasculitis and hypocomplementemic urticarial vasculitis syndrome. , 2004, Immunology and allergy clinics of North America.

[28]  D. Huston,et al.  Urticarial vasculitis , 1995, Clinical reviews in allergy & immunology.

[29]  M. Davis,et al.  Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis. , 1998, Journal of the American Academy of Dermatology.

[30]  D. Mehregan,et al.  Pathophysiology of urticarial vasculitis. , 1998, Archives of dermatology.

[31]  J. Toribio,et al.  Incidence of Leukocytoclastic Vasculitis in Chronic Idiopathic Urticaria; Study of 100 Cases , 1989, The American Journal of dermatopathology.

[32]  F. Granier,et al.  Urticaire systémique associée à une thyroïdite auto-immune , 1987 .

[33]  F. C. Mcduffie,et al.  Hypocomplementemia with cutaneous vasculitis and arthritis. Possible immune complex syndrome. , 1973, Mayo Clinic proceedings.

[34]  J. F. Patterson,et al.  Syndromes associated with allergic vasculitis. , 1956, The New England journal of medicine.

[35]  W. Wills.  TWO CASES OF HÆMORRHAGIC URTICARIA. , 1890 .